Molecular Templates, Inc. (NASDAQ:MTEM) Short Interest Update

Molecular Templates, Inc. (NASDAQ:MTEM) saw a significant drop in short interest in the month of September. As of September 30th, there was short interest totalling 141,900 shares, a drop of 25.4% from the September 15th total of 190,100 shares. Based on an average daily volume of 28,100 shares, the short-interest ratio is currently 5.0 days. Currently, 2.6% of the shares of the stock are short sold.

Molecular Templates Trading Down 0.7 %

Molecular Templates stock traded down $0.01 during trading hours on Friday, reaching $1.47. 2,177,114 shares of the stock were exchanged, compared to its average volume of 32,463. Molecular Templates has a twelve month low of $1.00 and a twelve month high of $6.85. The company has a market cap of $9.67 million, a P/E ratio of -0.54 and a beta of 1.15. The stock has a 50 day moving average of $1.41 and a two-hundred day moving average of $1.45.

Molecular Templates (NASDAQ:MTEM) last announced its quarterly earnings data on Wednesday, August 14th. The biotechnology company reported ($1.23) earnings per share (EPS) for the quarter. Molecular Templates had a negative net margin of 61.35% and a negative return on equity of 260.50%. The firm had revenue of $0.57 million during the quarter.

Molecular Templates Company Profile

Molecular Templates, Inc, a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB).